Human enterovirus-like particle vaccine development (2014–2016)

Grant type:
Sentinext Therapeutics
Researchers:
  • Director
    UQ Protein Expression Facility
    Affiliate Professor
    Australian Institute for Bioengineering and Nanotechnology
Funded by:
Sentinext Therapeutics